We are live on ! Find out more
Aberdeen Group

Aberdeen Group Portfolio holdings

AUM $61.9B
1-Year Est. Return 29.81%
This Fund
S&P 500
This Quarter Est. Return
+11.68%
1 Year Est. Return
+29.81%
3 Year Est. Return
+93.17%
5 Year Est. Return
+119.65%
10 Year Est. Return
AUM
$51B
AUM Growth
+$4.88B
Cap. Flow
+$834M
Cap. Flow %
1.63%
Top 10 Hldgs %
25.68%
Holding
986
New
26
Increased
432
Reduced
416
Closed
39

Top Buys

Rank Stock Value
1
KSPI icon
Kaspi.kz JSC
KSPI
+$260M
2
MSFT icon
Microsoft
MSFT
+$71.2M
3
CAH icon
Cardinal Health
CAH
+$61.4M
4
CLX icon
Clorox
CLX
+$47.7M
5
ACN icon
Accenture
ACN
+$46.1M

Sector Composition

Rank Sector Weight
1 Technology 28.39%
2 Healthcare 17.34%
3 Financials 11.02%
4 Consumer Discretionary 9.2%
5 Industrials 8.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FRT icon
651
Federal Realty Investment Trust
FRT
$10.9B
$5.6M 0.01%
54,808
+6,793
+14% +$687K
MGM icon
652
MGM Resorts International
MGM
$11.7B
$5.57M 0.01%
117,888
-8,484
-7% -$371K
HPP
653
Hudson Pacific Properties
HPP
$834M
$5.56M 0.01%
123,195
+366
+0.3% +$19.3K
TRU icon
654
TransUnion
TRU
$14.8B
$5.54M 0.01%
69,370
+980
+1% +$71.8K
RVTY icon
655
Revvity
RVTY
$12.3B
$5.5M 0.01%
52,408
-201
-0.4% -$21.4K
WRK
656
DELISTED
WestRock Company
WRK
$5.49M 0.01%
111,034
-920
-0.8% -$40.2K
ETNB
657
DELISTED
89bio
ETNB
$5.48M 0.01%
470,387
+256,195
+120% +$2.84M
COLD icon
658
Americold
COLD
$4.09B
$5.42M 0.01%
217,456
-371,745
-63% -$10.2M
NFE icon
659
New Fortress Energy
NFE
$101M
$5.26M 0.01%
172,060
-13,418
-7% -$441K
LNT icon
660
Alliant Energy
LNT
$19.4B
$5.25M 0.01%
104,251
+574
+0.6% +$28.2K
BURL icon
661
Burlington
BURL
$22B
$5.24M 0.01%
22,584
+334
+2% +$68.2K
FMC icon
662
FMC
FMC
$1.42B
$5.23M 0.01%
82,050
-259,918
-76% -$15.2M
PRCT icon
663
Procept Biorobotics
PRCT
$950M
$5.17M 0.01%
104,707
-1,293
-1% -$61.5K
JNPR
664
DELISTED
Juniper Networks
JNPR
$5.16M 0.01%
139,349
-31,160
-18% -$1.14M
ARDX icon
665
Ardelyx
ARDX
$1.24B
$5.12M 0.01%
700,865
-132,749
-16% -$1.14M
AKRO
666
DELISTED
Akero Therapeutics
AKRO
$5.03M 0.01%
199,237
+127,695
+178% +$3.07M
MRNS
667
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$5M 0.01%
552,572
EMN icon
668
Eastman Chemical
EMN
$7.8B
$4.98M 0.01%
49,728
SSNC icon
669
SS&C Technologies
SSNC
$17.8B
$4.9M 0.01%
76,130
+1,087
+1% +$67.5K
VOD icon
670
Vodafone
VOD
$34.9B
$4.85M 0.01%
544,900
-1,383,500
-72% -$12M
MTCH icon
671
Match Group
MTCH
$8.84B
$4.83M 0.01%
133,002
-688
-0.5% -$24.9K
FNF icon
672
Fidelity National Financial
FNF
$13.9B
$4.82M 0.01%
90,688
+1,314
+1% +$66.2K
BBWI icon
673
Bath & Body Works
BBWI
$4.01B
$4.81M 0.01%
96,207
-139
-0.1% -$6.24K
FFIV icon
674
F5
FFIV
$22.1B
$4.75M 0.01%
25,080
-1,496
-6% -$276K
CRNX icon
675
Crinetics Pharmaceuticals
CRNX
$8.86B
$4.74M 0.01%
101,196

Similar funds

Aberdeen Group's Q1 2024 Portfolio in Review

As of Q1 2024, Aberdeen Group held 986 positions worth $51B, up 11% from $46.1B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Aberdeen Group's Q1 2024 filing shows 26 new, 432 increased, 416 reduced and 39 closed positions. Its largest new stake was Kaspi.kz JSC: 2,541,596 shares worth $327M. The largest sale was Sociedad Química y Minera de Chile, an estimated $63.6M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.

  • Aberdeen Group's largest Q1 2024 buy was Kaspi.kz JSC: 2,541,596 shares worth $327M.
  • Aberdeen Group added most to Microsoft in Q1 2024, an estimated $71.2M increase.
  • Aberdeen Group's biggest Q1 2024 reduction was Sociedad Química y Minera de Chile, cutting an estimated $63.6M.
  • Aberdeen Group fully exited Splunk Inc in Q1 2024, selling an estimated $56.2M.
  • Aberdeen Group's ten largest holdings make up 26% of its $51B portfolio in Q1 2024.
  • Aberdeen Group opened 26 new positions and closed 39 in Q1 2024.
  • Aberdeen Group's portfolio value rose 11% quarter-over-quarter to $51B.

Based on Aberdeen Group's 13F filing for Q1 2024, filed 9 May 2024.